Inactive Instrument
Acura Pharmaceuticals, Inc. Stock Nasdaq
Stocks
US00509L8028
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.28M 2.86M 2.63M 2.45M 4.65M 312M 4.73M 31.67M 12.28M 153M 12.31M 12.04M 528M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 2.98M 2.74M 2.55M 4.84M 325M 4.92M 32.98M 12.78M 159M 12.82M 12.54M 549M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 01/04/2011 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 01/08/2024 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/02/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Wesson
BRD | Director/Board Member | 83 | 01/03/1998 |
William Skelly
CHM | Chairman | 75 | 01/10/1996 |
| Director/Board Member | 55 | 01/12/2002 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +4.44% | - | - | 59.98K | |
| +0.29% | +5.00% | +78.89% | +135.72% | 58.73B | |
| -3.12% | +3.48% | +72.79% | +94.67% | 53.92B | |
| -10.61% | +8.38% | -9.90% | -9.62% | 24.67B | |
| -0.30% | +6.82% | +13.60% | +428.91% | 24.19B | |
| +4.74% | +13.47% | +46.43% | +0.03% | 18.8B | |
| -0.29% | +9.58% | +44.35% | -28.08% | 17.61B | |
| +2.57% | +16.74% | +171.12% | +355.99% | 16.25B | |
| +3.50% | +4.92% | +26.07% | +192.26% | 14.04B | |
| +6.72% | +20.94% | +51.67% | - | 13.9B | |
| Average | +2.17% | +9.77% | +55.00% | +146.23% | 26.9B | |
| Weighted average by Cap. | +1.16% | +7.68% | +58.50% | +136.73% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.12M 2.86M 2.67M 5.06M 340M 5.15M 34.49M 13.37M 167M 13.4M 13.11M 574M | 1.56M 1.37M 1.25M 1.17M 2.22M 149M 2.25M 15.1M 5.85M 72.98M 5.87M 5.74M 251M |
| Net income | -1.21M -1.06M -969K -904K -1.71M -115M -1.74M -11.67M -4.52M -56.41M -4.54M -4.44M -194M | -879K -768K -705K -658K -1.25M -83.68M -1.27M -8.49M -3.29M -41.04M -3.3M -3.23M -141M |
| Net Debt | 5.86M 5.12M 4.7M 4.38M 8.31M 557M 8.45M 56.57M 21.93M 273M 21.99M 21.51M 942M | 135K 118K 108K 101K 192K 12.85M 195K 1.3M 505K 6.3M 507K 496K 21.72M |
Employees
-
